Authors



Paul S. Chan, MD, MSc

Latest:

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.


Maureen Trudeau, MD

Latest:

Closing the Personalized Medicine Information Gap: HER2 Test Documentation Practice

Despite universal access to HER2 testing in Ontario, variability in reporting by region and disease severity presents challenges for program evaluation and quality improvement initiatives.


Stephen S. Grubbs, MD

Latest:

Making Sense of Advanced Payment Models

The American Society of Clinical Oncology has developed the Patient-Centered Oncology Payment (PCOP) model with the hope that PCOP will be accepted by CMS as an advanced alternative payment model, and become available to medical oncologists as an alternative to the Merit-based Incentive Payment System.


Xiaoyan Huang, MD

Latest:

Managing Specialty Care in an Era of Heightened Accountability: Emphasizing Quality and Accelerating Savings

The authors report on a conceptual "specialty ACO" design in cardiology in which cardiology-specific historic spending targets are created to capture cardiovascular disease—related reimbursement and a quality measurement system is introduced.


Nancy Takahashi, MPH

Latest:

Care Coordination to Increase Referrals to Smoking Cessation Telephone Counseling: A Demonstration Project

An intervention to increase tobacco treatment rates through care coordination for telephone counseling was effective in raising referral rates and in achieving excellent long-term abstinence.


Bradley G. Hammill, MS

Latest:

Removing a Constraint on Hospital Utilization: A Natural Experiment in Maryland

In 2001, Maryland began to reimburse hospitals for excess volume at full case rates. The authors investigated the impact on hospital utilization and finances.



Amber Servi, BA

Latest:

Modes of Delivery for Interventions to Improve Cardiovascular Medication Adherence

In this review of randomized controlled trials designed to improve adherence to cardiovascular medications, electronic interventions and in-person, pharmacy-based interventions showed the highest success rates.


Herbert C. Heien, MS

Latest:

Enhanced Risk Prediction Model for Emergency Department Use and Hospitalizations in Patients in a Primary Care Medical Home

An enhanced risk model incorporating medication use, prior healthcare utilization, and mental health with comorbid health conditions predicts healthcare utilization better than health conditions alone.


Robert W. Gladden, MA, BS

Latest:

Maternal Mental Health and Infant Mortality for Healthy-Weight Infants

To address infant mortality, focusing only on babies who were born prematurely or with a low birth weight will be missing an attention-worthy segment of the population.






Jacqueline Mix, MPH

Latest:

Functional Status and Readmissions in Unilateral Hip Fractures

Functional status is an important predictor of an acute care readmission in patients who have had a unilateral hip fracture.




Hongsoo Kim, PhD, MPH

Latest:

Scheduled and Unscheduled Hospital Readmissions Among Patients With Diabetes

This population-based study examines socioeconomic and clinical factors associated with scheduled and unscheduled readmissions after discharge among older patients with diabetes.


David H. Howard, PhD

Latest:

Provider-Owned Insurers in the Individual Market

Provider-owned insurers sell individual policies in areas that cover 62% of the US population and have premiums similar to policies of traditional insurers.



Charles E. Mahan, PharmD, RPh, PhC

Latest:

The Impact of Direct Oral Anticoagulants in the Managed Care Environment

Participants will learn about the prevalence, incidence, and economic impact of venous thromboembolism and atrial fibrillation on patients, as well as the associated treatments and clinical data relating to efficacy, safety, and cost-efficacy.


Marie Smith, PharmD

Latest:

Analysis of 2016 Connecticut ACO Medicare Shared Savings Program Data to Identify Opportunities for Population Health Pharmacist Services

Publicly reported Medicare Shared Savings Program accountable care organization (ACO) data can be analyzed to identify cost and medication-related quality performance improvement opportunities to support pharmacist integration into ACO population health services.


Lisa Tomai, MS

Latest:

Payer Effects of Personalized Preventive Care for Patients With Diabetes

We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.


Reena L. Pande, MD, MSc

Latest:

Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce Costs

Successful patient engagement in a nationally available, remotely delivered behavioral health intervention can significantly improve medical outcomes and lower healthcare costs.




Darius N. Lakdawalla, PhD

Latest:

Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering Therapies

Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.


Alex Lowenthal, MPA

Latest:

Association Between Personal Health Record Enrollment and Patient Loyalty

Patients with online access to key components of their personal health records were 2.6 times more likely than nonusers to remain health plan members.


Megan E. Coombes, MSc

Latest:

Longitudinal Adherence to Colorectal Cancer Screening Guidelines

Over a 10-year time frame, longitudinal adherence to current colorectal cancer (CRC) screening guidelines was less than ideal in a large, continuously insured US population at average risk for CRC.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo